View of FDA Regulatory Milestones, Announcement Framing, and Biotechnology Stock Returns: Evidence on the Feasibility of an AI-Native Comparison, 2019-2026

Return to Issue Details FDA Regulatory Milestones, Announcement Framing, and Biotechnology Stock Returns: Evidence on the Feasibility of an AI-Native Comparison, 2019-2026 Download Download PDF